FDA Approved: GANCICLOVIR — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for GANCICLOVIR SODIUM from Fresenius Kabi USA, LLC. This action approves a generic version of ganciclovir.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Cytomegalovirus Retinitis

Drugs mentioned

• GANCICLOVIR (GANCICLOVIR SODIUM)

Snippet

SUPPL AP for GANCICLOVIR (GANCICLOVIR SODIUM)